Orchid Pharma Limited has informed the Exchange about Schedule of investors meet
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the exchanges about an upcoming Analysts/Investors Earning Call scheduled for Tuesday, November 11, 2025 at 4:30 PM IST. The call is being hosted by Systematix Institutional Equities and will discuss the company's financial performance and results for Q2 and the half year of FY2025-26, ended September 30, 2025. The management will be represented by Managing Director Manish Dhanuka, Whole Time Director Mridul Dhanuka, and CFO Sunil Kumar Gupta. Dial-in numbers have been provided for participants from India, USA, UK, Singapore, and Hong Kong. No financial figures have been disclosed in this filing — it is purely a schedule/intimation notice.
This is a routine compliance filing and does not contain any new financial data or material information. Investors should watch for the actual Q2 FY26 results, which are expected to be discussed during the call on November 11. The stock price is unlikely to react materially to this announcement alone.